LianBio (LIAN) Competitors $0.19 -0.01 (-5.10%) As of 04/23/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendInsider TradesSEC FilingsTrendsBuy This Stock LIAN vs. HLVX, BDTX, KYTX, EXOZ, TCRX, IGMS, GALT, ENTX, ATOS, and VORShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include HilleVax (HLVX), Black Diamond Therapeutics (BDTX), Kyverna Therapeutics (KYTX), Exozymes (EXOZ), TScan Therapeutics (TCRX), IGM Biosciences (IGMS), Galectin Therapeutics (GALT), Entera Bio (ENTX), Atossa Therapeutics (ATOS), and Vor Biopharma (VOR). These companies are all part of the "pharmaceutical products" industry. LianBio vs. HilleVax Black Diamond Therapeutics Kyverna Therapeutics Exozymes TScan Therapeutics IGM Biosciences Galectin Therapeutics Entera Bio Atossa Therapeutics Vor Biopharma HilleVax (NASDAQ:HLVX) and LianBio (NASDAQ:LIAN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, media sentiment, risk, valuation and institutional ownership. Do analysts recommend HLVX or LIAN? HilleVax presently has a consensus price target of $3.00, suggesting a potential upside of 62.16%. Given HilleVax's stronger consensus rating and higher possible upside, equities analysts clearly believe HilleVax is more favorable than LianBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HilleVax 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is HLVX or LIAN more profitable? LianBio's return on equity of -33.17% beat HilleVax's return on equity.Company Net Margins Return on Equity Return on Assets HilleVaxN/A -67.27% -51.99% LianBio N/A -33.17%-30.19% Which has more risk and volatility, HLVX or LIAN? HilleVax has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, LianBio has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Which has higher valuation and earnings, HLVX or LIAN? HilleVax is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHilleVaxN/AN/A-$123.57M-$3.00-0.62LianBioN/AN/A-$110.29M-$0.81-0.23 Does the media favor HLVX or LIAN? In the previous week, HilleVax's average media sentiment score of 0.00 equaled LianBio'saverage media sentiment score. Company Overall Sentiment HilleVax Neutral LianBio Neutral Does the MarketBeat Community believe in HLVX or LIAN? HilleVax received 6 more outperform votes than LianBio when rated by MarketBeat users. Likewise, 55.56% of users gave HilleVax an outperform vote while only 36.36% of users gave LianBio an outperform vote. CompanyUnderperformOutperformHilleVaxOutperform Votes1055.56% Underperform Votes844.44% LianBioOutperform Votes436.36% Underperform Votes763.64% Do institutionals & insiders believe in HLVX or LIAN? 86.4% of HilleVax shares are held by institutional investors. Comparatively, 74.8% of LianBio shares are held by institutional investors. 71.1% of HilleVax shares are held by company insiders. Comparatively, 7.6% of LianBio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryHilleVax beats LianBio on 7 of the 12 factors compared between the two stocks. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.51M$120.63M$5.42B$7.71BDividend YieldN/A3.69%5.44%4.33%P/E Ratio-0.233.0022.1818.31Price / SalesN/A4,182.26397.31107.09Price / CashN/A13.0238.2034.62Price / Book0.0734.586.834.25Net Income-$110.29M-$90.45M$3.20B$247.51M7 Day Performance-5.10%1.71%5.79%6.08%1 Month Performance-2.87%-3.74%-5.53%-3.77%1 Year Performance-32.93%90.77%16.85%4.60% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.19-5.1%N/A-29.3%$20.51MN/A-0.23110Gap DownHLVXHilleVax2.1074 of 5 stars$1.73+3.9%$3.00+73.9%-85.5%$85.99MN/A-0.5520BDTXBlack Diamond Therapeutics3.0803 of 5 stars$1.54+3.0%$14.60+851.1%-68.5%$85.84MN/A-1.1490Positive NewsKYTXKyverna Therapeutics1.2312 of 5 stars$2.00+0.7%$18.33+814.8%-88.9%$85.79M$7.03M-0.5796EXOZExozymesN/A$10.25-2.1%N/AN/A$85.77MN/A0.0029Gap UpTCRXTScan Therapeutics2.5108 of 5 stars$1.54+0.7%$9.33+505.7%-77.5%$85.74M$2.82M-1.43100IGMSIGM Biosciences3.1148 of 5 stars$1.42+10.9%$5.50+287.3%-81.9%$84.88M$2.68M-0.39190News CoverageGALTGalectin Therapeutics0.918 of 5 stars$1.34+2.3%$11.00+720.9%-60.0%$84.60MN/A-1.839ENTXEntera Bio2.2735 of 5 stars$1.85+0.8%$10.00+439.4%-6.8%$84.21M$181,000.00-7.1320News CoveragePositive NewsATOSAtossa Therapeutics2.2083 of 5 stars$0.65+2.1%$7.13+996.2%-50.5%$83.96MN/A-2.958Analyst ForecastAnalyst RevisionNews CoverageGap UpVORVor Biopharma2.2272 of 5 stars$0.67-2.2%$8.86+1,220.0%-59.6%$83.78MN/A-0.41140Gap Up Related Companies and Tools Related Companies HLVX Alternatives BDTX Alternatives KYTX Alternatives EXOZ Alternatives TCRX Alternatives IGMS Alternatives GALT Alternatives ENTX Alternatives ATOS Alternatives VOR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIAN) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LIAN Stock Free LIAN Stock Alerts